Valuation: H&R GmbH & Co KgaA

Market Cap 22Cr 25Cr 21Cr 19Cr 36Cr 2.44TCr 37Cr 246.53Cr 97Cr 1.2TCr 96Cr 94Cr 4.13TCr P/E 2026 *
38.2x
P/E 2027 * 28.2x
Enterprise Value 38Cr 43Cr 35Cr 32Cr 61Cr 4.14TCr 62Cr 418.86Cr 164.28Cr 2.03TCr 162.45Cr 158.9Cr 7.02TCr EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.29x
Free-Float
21.97%
Yield 2026 *
0.83%
Yield 2027 * 0.83%
15/05 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/01 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
15/11 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/11 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/25/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/25/15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/25/16 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/25/14 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/25/17 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/25/09 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/25/27 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
27/25/27 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26Cr
+1.40%-0.48%+11.18%+33.69% 13TCr
+9.92%+1.27%+648.59%+187.46% 4.48TCr
+0.57%+0.96%-5.83%-40.68% 4.17TCr
-2.56%-3.22%+20.15%-26.31% 3.17TCr
+1.97%+0.88%+32.82%+55.56% 2.18TCr
+3.00%+8.89%-8.50%-37.78% 1.82TCr
-5.08%-12.40%+331.83%+569.58% 1.81TCr
-0.44%-1.93%+17.74%+403.91% 1.73TCr
-3.36%-14.97%+57.04%+190.38% 1.73TCr
Average +0.55%-1.43%+122.78%+148.42% 3.75TCr
Weighted average by Cap. +1.50%-1.31%+114.88%+92.66%

Financials

2026 *2027 *
Net sales 129.35Cr 147.47Cr 119.8Cr 110.23Cr 208.5Cr 14TCr 212.56Cr 1.43TCr 560.02Cr 6.93TCr 553.78Cr 541.67Cr 24TCr 133.02Cr 151.66Cr 123.21Cr 113.36Cr 214.42Cr 15TCr 218.59Cr 1.47TCr 575.93Cr 7.13TCr 569.52Cr 557.06Cr 25TCr
Net income 58.49L 66.68L 54.17L 49.84L 94.28L 64Cr 96.11L 6.46Cr 2.53Cr 31Cr 2.5Cr 2.45Cr 108.24Cr 79.95L 91.15L 74.05L 68.13L 1.29Cr 87Cr 1.31Cr 8.83Cr 3.46Cr 43Cr 3.42Cr 3.35Cr 147.96Cr
Net Debt 16Cr 18Cr 14Cr 13Cr 25Cr 1.7TCr 26Cr 172.33Cr 68Cr 836.56Cr 67Cr 65Cr 2.89TCr 16Cr 18Cr 15Cr 13Cr 25Cr 1.72TCr 26Cr 174.23Cr 68Cr 845.79Cr 68Cr 66Cr 2.92TCr
Logo H&R GmbH & Co KgaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-